GLP-1 receptor agonists for obesity: eligibility across 99 countries
11Citations signalées
41Institutions associées
24Pays d’affiliation
Résumé indisponible dans les métadonnées reçues.
Institutions
Washington University in St. LouisEmory UniversityBrigham and Women's HospitalUniversity of MichiganUniversity of BergenHeidelberg UniversityUniversity Hospital HeidelbergIndus HospitalNational Institute of Health Dr. Ricardo JorgeMinistry of HealthUniversidade Federal de Minas GeraisUniversity of MaltaEduardo Mondlane UniversityTehran University of Medical SciencesBaqai Medical UniversityUniversity of the West IndiesUniversité d'Abomey-CalaviUniversity of CopenhagenZanzibar UniversityHarvard UniversityStellenbosch UniversityBerlin Institute of Health at Charité - Universitätsmedizin BerlinCharité - Universitätsmedizin BerlinUniversidade da PazUniversity of AbujaQueen Mary University of LondonUniversidad Hospital ItalianoCaribbean Public Health AgencyKiel Institute for the World EconomyHuman Sciences Research CouncilNational University Health SystemUniversity of GöttingenHarvard Global Health InstituteCentro de Investigación Biomédica en Red de Epidemiología y Salud PúblicaUniversidad Autónoma de MadridHeinrich Heine University DüsseldorfThe George Institute for Global HealthDesmond Tutu HIV FoundationUniversity of Cape TownWestern Cape Department of HealthInstitute of Nutrition of Central America and Panama
Sujets associés
Diabetes Treatment and ManagementBariatric Surgery and OutcomesPharmacology and Obesity Treatment